Literature DB >> 18242985

Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).

Alessio Innocenti1, Daniela Vullo, Andrea Scozzafava, Claudiu T Supuran.   

Abstract

The inhibition of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1) with three phenols was investigated. Phenol was an effective CA I-IV, IX, XII and XIV inhibitor (K(I)s of 2.7-11.5 microM) and a less effective one against the other isoforms, CA VA, VB, VI, VII, and XIII (K(I)s of 208-710 micraoM). 3,5-Difluorophenol was an effective inhibitor of CA III, IV, IX, and XIV (K(I)s of 0.71-10.7 microM) being a weaker one for CA I, II, VA, VB, VI, VII, XII, and XIII (K(I)s of 33.9-163 microM). Clioquinol (5-chloro-7-iodo-8-quinolinol) was the best phenol inhibitor against all isozymes, with inhibition constants in the range of 3.3-16.0 microM. These data prove that the phenol OH moiety can be considered as a new 'zinc-water binding group' for the design of CA inhibitors possessing a different inhibition mechanism as compared to the classical sulfonamide inhibitors that bind the metal ion within the active site cavity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242985     DOI: 10.1016/j.bmcl.2008.01.077

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

1.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.

Authors:  Fabrizio Carta; Mayank Aggarwal; Alfonso Maresca; Andrea Scozzafava; Robert McKenna; Emanuela Masini; Claudiu T Supuran
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

2.  Potent inhibition of dinuclear zinc(II) peptidase, an aminopeptidase from Aeromonas proteolytica, by 8-quinolinol derivatives: inhibitor design based on Zn2+ fluorophores, kinetic, and X-ray crystallographic study.

Authors:  Kengo Hanaya; Miho Suetsugu; Shinya Saijo; Ichiro Yamato; Shin Aoki
Journal:  J Biol Inorg Chem       Date:  2012-02-05       Impact factor: 3.358

3.  Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.

Authors:  David P Martin; Seth M Cohen
Journal:  Chem Commun (Camb)       Date:  2012-04-24       Impact factor: 6.222

4.  Bidentate Zinc chelators for alpha-carbonic anhydrases that produce a trigonal bipyramidal coordination geometry.

Authors:  Johannes Schulze Wischeler; Alessio Innocenti; Daniela Vullo; Arpita Agrawal; Seth M Cohen; Andreas Heine; Claudiu T Supuran; Gerhard Klebe
Journal:  ChemMedChem       Date:  2010-09-03       Impact factor: 3.466

5.  Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations.

Authors:  Jason Wagner; Balendu Sankara Avvaru; Arthur H Robbins; Andrea Scozzafava; Claudiu T Supuran; Robert McKenna
Journal:  Bioorg Med Chem       Date:  2010-06-15       Impact factor: 3.641

Review 6.  Carbonic anhydrase inhibition with natural products: novel chemotypes and inhibition mechanisms.

Authors:  Claudiu T Supuran
Journal:  Mol Divers       Date:  2010-08-28       Impact factor: 2.943

Review 7.  New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents.

Authors:  Kuo-Ting Chen; Yann Seimbille
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

Review 8.  Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.

Authors:  Narges K Tafreshi; Mark C Lloyd; Marilyn M Bui; Robert J Gillies; David L Morse
Journal:  Subcell Biochem       Date:  2014

9.  Potential anticancer activities of Rhus coriaria (sumac) extract against human cancer cell lines.

Authors:  Sami A Gabr; Ahmad H Alghadir
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

10.  Activation of Two Different Drugs Used in Alzheimer's Disease Treatment on Human Carbonic Anhydrase Isozymes I and II Activity: an In Vitro Study.

Authors:  Esra DiLEK
Journal:  Turk J Pharm Sci       Date:  2017-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.